Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification Theory: an Integrated Study

NCT07286812 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT07286812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07286812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification Theory: an Integrated Study
Lead sponsor
First Hospital of China Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
December 25, 2025
Completion date
July 31, 2026
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease